Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ELTROMBOPAG Cause Concomitant disease aggravated? 52 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 52 reports of Concomitant disease aggravated have been filed in association with ELTROMBOPAG. This represents 1.0% of all adverse event reports for ELTROMBOPAG.

52
Reports of Concomitant disease aggravated with ELTROMBOPAG
1.0%
of all ELTROMBOPAG reports
20
Deaths
21
Hospitalizations

How Dangerous Is Concomitant disease aggravated From ELTROMBOPAG?

Of the 52 reports, 20 (38.5%) resulted in death, 21 (40.4%) required hospitalization, and 7 (13.5%) were considered life-threatening.

Is Concomitant disease aggravated Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ELTROMBOPAG. However, 52 reports have been filed with the FAERS database.

What Other Side Effects Does ELTROMBOPAG Cause?

Platelet count decreased (968) Death (629) Drug ineffective (554) Product use in unapproved indication (303) Thrombocytopenia (262) Off label use (255) Headache (229) Pyrexia (229) Haemoglobin decreased (213) Pneumonia (204)

What Other Drugs Cause Concomitant disease aggravated?

SACUBITRIL\VALSARTAN (533) SECUKINUMAB (461) FINGOLIMOD (425) MACITENTAN (286) OMALIZUMAB (186) SELEXIPAG (166) METHOTREXATE (150) RUXOLITINIB (142) OCTREOTIDE (125) BOSENTAN (123)

Which ELTROMBOPAG Alternatives Have Lower Concomitant disease aggravated Risk?

ELTROMBOPAG vs ELTROMBOPAG OLAMINE ELTROMBOPAG vs ELUXADOLINE ELTROMBOPAG vs ELVITEGRAVIR ELTROMBOPAG vs EMAPALUMAB ELTROMBOPAG vs EMAPALUMAB-LZSG

Related Pages

ELTROMBOPAG Full Profile All Concomitant disease aggravated Reports All Drugs Causing Concomitant disease aggravated ELTROMBOPAG Demographics